I guess it would cover anything made with the same active ingredient rhBMP-2. Which would you want to use going forward?
Dr. Carragee added that the Amplify study findings had potential implications for patients who received Infuse, because both products contained the same active ingredient, a bioengineered bone growth protein known as rhBMP-2.
Wrong. There have been zero reported cases of cancer with Infuse. Sorry but believing Amplify's failure has anything to do with BONE or any of the other dozens of allograft processors is wishful thinking.